Analyze Diet

Topic:Vaccine

Vaccination in horses involves the administration of biological preparations designed to stimulate the equine immune system to recognize and combat specific pathogens. Vaccines are formulated to prevent or reduce the severity of infectious diseases that can affect equine health and performance. Common vaccines for horses include those for equine influenza, tetanus, equine herpesvirus, and West Nile virus. The administration schedule and type of vaccine can vary based on factors such as geographic location, age, and use of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in horses, as well as their impact on equine health management.
African horse sickness in The Gambia: circulation of a live-attenuated vaccine-derived strain.
Epidemiology and infection    May 9, 2011   Volume 140, Issue 3 462-465 doi: 10.1017/S095026881100080X
Oura CA, Ivens PA, Bachanek-Bankowska K, Bin-Tarif A, Jallow DB, Sailleau C, Maan S, Mertens PC, Batten CA.African horse sickness virus serotype 9 (AHSV-9) has been known for some time to be circulating amongst equids in West Africa without causing any clinical disease in indigenous horse populations. Whether this is due to local breeds of horses being resistant to disease or whether the AHSV-9 strains circulating are avirulent is currently unknown. This study shows that the majority (96%) of horses and donkeys sampled across The Gambia were seropositive for AHS, despite most being unvaccinated and having no previous history of showing clinical signs of AHS. Most young horses (<3 years) were seropo...
Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
Vaccine    May 5, 2011   Volume 29, Issue 28 4608-4612 doi: 10.1016/j.vaccine.2011.04.058
Minke JM, Siger L, Cupillard L, Powers B, Bakonyi T, Boyum S, Nowotny N, Bowen R.The emergence of lineage 2 strains of WNV in Europe as a cause of clinical disease and mortality in horses raised the question whether the existing WNV vaccines, all based on lineage 1 strains, protect against circulating lineage 2 strains of WNV. In the present paper we have determined the level of cross protection provided by the recombinant ALVAC(®)-WNV vaccine in a severe challenge model that produces clinical signs of WNV type 2 disease. Ten horses were vaccinated twice at 4 weeks interval with one dose of the ALVAC-WNV vaccine formulated at the minimum protective dose. A further 10 hors...
Facing the threat of equine influenza.
Equine veterinary journal    April 16, 2011   Volume 43, Issue 3 250-258 doi: 10.1111/j.2042-3306.2010.00357.x
Elton D, Bryant N.Despite the availability of vaccines, equine influenza virus (EIV) continues to pose a threat to the racing industry. The virus spreads rapidly in unprotected populations and large scale outbreaks, such as those in South Africa in 2003 and Australia in 2007, can cost billions of pounds. Like other influenza viruses, EIV undergoes antigenic variation, enabling it to evade antibodies generated against previous infection or vaccination. The UK has an active surveillance programme to monitor antigenic drift and participates in an international collaboration with other countries in Europe, Japan an...
Genome-scale evolution and phylodynamics of equine H3N8 influenza A virus.
Journal of virology    March 23, 2011   Volume 85, Issue 11 5312-5322 doi: 10.1128/JVI.02619-10
Murcia PR, Wood JL, Holmes EC.Equine influenza viruses (EIVs) of the H3N8 and H7N7 subtypes are the causative agents of an important disease of horses. While EIV H7N7 apparently is extinct, H3N8 viruses have circulated for more than 50 years. Like human influenza viruses, EIV H3N8 caused a transcontinental pandemic followed by further outbreaks and epidemics, even in populations with high vaccination coverage. Recently, EIV H3N8 jumped the species barrier to infect dogs. Despite its importance as an agent of infectious disease, the mechanisms that underpin the evolutionary and epidemiological dynamics of EIV are poorly und...
A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses – a randomised blind study.
Vaccine    March 17, 2011   Volume 29, Issue 22 3917-3922 doi: 10.1016/j.vaccine.2011.03.003
Gildea S, Arkins S, Walsh C, Cullinane A.Protection against equine influenza virus (EIV) relies largely on the production of circulating antibodies specific for the haemagglutinin (HA) glycoprotein. The objective of this study was to determine the antibody response of National Hunt horses in training to booster vaccination. The antibody response to the six equine influenza vaccines available in Ireland (three whole inactivated vaccines, two subunit vaccines and a canary pox recombinant vaccine), was monitored by single radial haemolysis (SRH) for six months post vaccination. There was no significant difference between antibody respon...
Vaccination elicits a prominent acute phase response in horses.
Veterinary journal (London, England : 1997)    March 2, 2011   Volume 191, Issue 2 199-202 doi: 10.1016/j.tvjl.2011.01.019
Andersen SA, Petersen HH, Ersbøll AK, Falk-Rønne J, Jacobsen S.European and American guidelines for vaccination against tetanus and influenza in horses recommend annual and annual/semi-annual vaccinations, respectively, against the two pathogens. Too-frequent vaccination may, however, have adverse effects, among other things because an inflammatory response is elicited with subsequent alterations in homeostasis. The objective of the study was to compare the acute phase response (APR) in 10 horses following administration of two different types of vaccines, namely, an inactivated Immune Stimulating COMplex (ISCOM) vaccine and a live recombinant vector vacc...
Cardiac troponin I concentrations in ponies challenged with equine influenza virus.
Journal of veterinary internal medicine    February 11, 2011   Volume 25, Issue 2 339-344 doi: 10.1111/j.1939-1676.2011.0680.x
Durando MM, Birks EK, Hussey SB, Lunn DP.Myocarditis is thought to occur secondary to equine influenza virus (EIV) infections in horses, but there is a lack of published evidence. Objective: We proposed that EIV challenge infection in ponies would cause myocardial damage, detectable by increases in plasma cardiac troponin I (cTnI) concentrations. Methods: Twenty-nine influenza-naïve yearling ponies: 23 were part of an influenza vaccine study (11 unvaccinated and 12 vaccinated), and were challenged with 10⁸ EID₅₀ EIV A/eq/Kentucky/91 6 months after vaccination. Six age-matched healthy and unvaccinated ponies concurrently housed...
Specific antibody responses to West Nile virus infections in horses preimmunized with inactivated Japanese encephalitis vaccine: evaluation of blocking enzyme-linked immunosorbent assay and complement-dependent cytotoxicity assay.
Vector borne and zoonotic diseases (Larchmont, N.Y.)    January 22, 2011   Volume 11, Issue 8 1093-1098 doi: 10.1089/vbz.2010.0094
Kitai Y, Shirafuji H, Kanehira K, Kamio T, Kondo T, Konishi E.West Nile virus (WNV) and Japanese encephalitis (JE) virus are distributed separately in the world with some exceptions. There is a concern that WNV may invade into Asia where JE virus exists. On and after such invasion, any differential diagnosis could be complicated by serological crossreactivities. We previously demonstrated experimentally using horses infected with WNV that preimmunization with inactivated JE vaccine considerably affected the ability of neutralization tests and immunoglobulin M (IgM) antibody-capture enzyme-linked immunosorbent assay (ELISA) to diagnose WNV infection. Here...
Full genome sequence and virulence analyses of the recent equine isolate of Japanese encephalitis virus.
The Journal of veterinary medical science    January 11, 2011   Volume 73, Issue 6 813-816 doi: 10.1292/jvms.10-0502
Shimojima M, Nagao Y, Shimoda H, Tamaru S, Yamanaka T, Matsumura T, Kondo T, Maeda K.In the past 25 years, there has been only one case of Japanese encephalitis in horses in Japan. We determined the full genome sequence of the Japanese encephalitis virus (JEV) strain JEV/eq/Tottori/2003 isolated from an afflicted horse and also analyzed its virulence in mice. The sequence analysis showed that the genome of JEV/eq/Tottori/2003 is similar to that of genotype I, a dominant genotype of JEV presently circulating in Japan. Its neurovirulence, but not neuroinvasiveness, was still as high as it was for genotype III, thus indicating the necessity for continuation of a vaccination progr...
Use of a gonadotrophin-releasing hormone vaccine in headshaking horses.
The Veterinary record    December 17, 2010   Volume 168, Issue 1 19 doi: 10.1136/vr.c5992
Pickles KJ, Berger J, Davies R, Roser J, Madigan JE.The aim of this study was to investigate the use of a gonadotrophin-releasing hormone (GnRH) vaccine in the treatment of headshaking in horses. Fifteen geldings received two doses of the GnRH vaccine four weeks apart. Serum was collected before and after vaccination to measure concentrations of luteinising hormone (LH) (10 horses) and follicle-stimulating hormone (FSH) (six horses). Owners recorded the frequency of seven common headshaking behaviours using a visual analogue scale (VAS) before vaccination and at two, four, eight, 12, 16 and 20 weeks after vaccination. Serum LH (P=0.008) and FSH...
Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
Archives of virology    December 7, 2010   Volume 156, Issue 2 353-357 doi: 10.1007/s00705-010-0877-8
Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Wang F, Shen R, Kong X, Zhou J.A lentiviral vaccine, live attenuated equine infectious anemia virus (EIAV) vaccine, was developed in the 1970s, and this has made tremendous contributions to the control of equine infectious anemia (EIA) in China. Four key virus strains were generated during the attenuation of the EIAV vaccine: the original Liao-Ning strain (EIAV(LN40)), a donkey-adapted virulent strain (EIAV(DV117)), a donkey-leukocyte-attenuated vaccine strain (EIAV(DLV121)), and a fetal donkey dermal cell (FDD)-adapted vaccine strain (EIAV(FDDV13)). In this study, we analyzed the proviral genomes of these four EIAV strains...
Reemergence of rabies in Chhukha district, Bhutan, 2008.
Emerging infectious diseases    December 3, 2010   Volume 16, Issue 12 1925-1930 doi: 10.3201/eid1612.100958
Tenzin , Sharma B, Dhand NK, Timsina N, Ward MP.From January through July 2008, rabies reemerged in the Chhukha district of southwestern Bhutan. To clarify the distribution and direction of spread of this outbreak, we mapped reported cases and conducted directional tests (mean center and standard deviational ellipse). The outbreak resulted in the death of 97 animals (42 cattle, 52 dogs, and 3 horses). Antirabies vaccine was given free of charge to ≈674 persons suspected to have been exposed. The outbreak spread south to north and appeared to follow road networks, towns, and areas of high human density associated with a large, free-roaming...
Envelope protein E1 as vaccine target for western equine encephalitis virus.
Vaccine    December 3, 2010   Volume 29, Issue 4 813-820 doi: 10.1016/j.vaccine.2010.11.009
Swayze RD, Bhogal HS, Barabé ND, McLaws LJ, Wu JQ.Western equine encephalitis virus (WEEV) is a mosquito-borne RNA virus which causes lethal infection in humans and equines. There are no commercial vaccines or anti-WEEV drugs available for humans. We used replication-defective, human adenovirus serotype-5 (HAd5) as a delivery vector for developing WEEV vaccine. Our previous study found delivery of both E1 and E2 envelope proteins of WEEV by HAd5 vector offers complete protection against lethal challenge of WEEV. In this paper, we constructed a HAd5-vectored E1 vaccine, Ad5-E1. Mice given single-dose vaccination of Ad5-E1 were completely prote...
A multiphasic typing approach to subtype Streptococcus equi subspecies equi. Lanka S, Borst LB, Patterson SK, Maddox CW.The objective of the present investigation was to differentiate between strains of Streptococcus equi subspecies equi implicated in abscess formation in vaccinated horses. Streptococcus equi isolates recovered from clinical specimens associated with equine strangles cases submitted to the University of Illinois Veterinary Diagnostic Laboratory were compared with S. equi isolates representing at least 12 lots of a commercial modified live vaccine (MLV) to determine whether the isolates obtained from the abscesses were vaccine or wild type. Genotyping techniques evaluated included enterobacteria...
Antibody responses induced by Japanese whole inactivated vaccines against equine influenza virus (H3N8) belonging to Florida sublineage clade2.
The Journal of veterinary medical science    November 19, 2010   Volume 73, Issue 4 483-485 doi: 10.1292/jvms.10-0408
Yamanaka T, Bannai H, Nemoto M, Tsujimura K, Kondo T, Matsumura T.In 2010, the World Organisation for Animal Health recommended the inclusion of a Florida sublineage clade2 strain of equine influenza virus (H3N8), which is represented by A/equine/Richmond/1/07 (Richmond07), in equine influenza vaccines. Here, we evaluate the antigenic differences between Japanese vaccine strains and Richmond07 by performing hemagglutination inhibition (HI) assays. Ferret antiserum raised to A/equine/La Plata/93 (La Plata93), which is a Japanese vaccine strain, reacted with Richmond07 at a similar titer to La Plata93. Moreover, two hundred racehorses exhibited similar geometr...
The effect of heterotypic infections of older horses with equine influenza virus type-2 on some clinical and immunological parameters.
Polish journal of veterinary sciences    November 3, 2010   Volume 13, Issue 3 515-523 
Zaleska M, Anusz K, Winnicka A, Kita J.Twelve horses, all of them 10 years old, were vaccinated intramuscularly on 0 and 28 days of the experiment with inactivated vaccine containing only antigens of A-equi-2/Miami/63. Another three unvaccinated horses, each at the age of 10 years, were the negative control group. One, ten-year-old horse was vaccinated with commercial inactivated vaccine containing both antigens of A-equi-2/Miami/63 as well as A-equi-1/Praha/56 as positive control. Three horses were challenged intranasally with homotypic strain of Miami/63, while six other were challenged with heterotypic strains--three with Suffol...
Immunocontraception in wild horses (Equus caballus) extends reproductive cycling beyond the normal breeding season.
PloS one    October 26, 2010   Volume 5, Issue 10 e13635 doi: 10.1371/journal.pone.0013635
Nuñez CM, Adelman JS, Rubenstein DI.Although the physiological effects of immunocontraceptive treatment with porcine zona pellucida (PZP) have been well studied, little is known about PZP's effects on the scheduling of reproductive cycling. Recent behavioral research has suggested that recipients of PZP extend the receptive breeding period into what is normally the non-breeding season. Results: To determine if this is the case, we compiled foaling data from wild horses (Equus caballus) living on Shackleford Banks, North Carolina for 4 years pre- and 8 years post-contraception management with PZP (pre-contraception, n = 65 births...
Changes in Serum Antibody Levels after Vaccination for Strangles and after Intranasal Challenge with Streptococcus equi subsp. equi in Horses.
Journal of equine science    October 22, 2010   Volume 21, Issue 3 33-37 doi: 10.1294/jes.21.33
Hobo S, Niwa H, Anzai T, Jones JH.In this study, to evaluate the influence of strangles vaccination on serological test results, we investigated the changes in strangles serum antibody levels in horses after vaccination and subsequent intranasal challenge with S. equi. The horses were vaccinated for strangles with either a component vaccine (Group C) or a live vaccine (Group L). We measured changes in strangles serum antibody levels weekly for 20 weeks after vaccinating horses twice for strangles over a 3-week interval, and for 7 weeks after intranasal challenge with S. equi in the same horses. Serum antibody responses to the ...
Equine influenza – surveillance and control.
Influenza and other respiratory viruses    October 21, 2010   Volume 4, Issue 6 339-344 doi: 10.1111/j.1750-2659.2010.00176.x
Cullinane A, Elton D, Mumford J.Equine influenza virus (EIV) is considered the most important respiratory virus of horses because it is highly contagious and has the potential to disrupt major equestrian events. Equine influenza (EI) can be controlled by vaccination but it has been demonstrated repeatedly in the field that antigenic drift impacts on vaccine efficacy. EI surveillance maintains awareness of emergence and international spread of antigenic variants. It not only serves as an early warning system for horse owners, trainers and veterinary clinicians but is fundamental to influenza control programmes based on vaccin...
Serologic evidence of the recent circulation of Saint Louis encephalitis virus and high prevalence of equine encephalitis viruses in horses in the Nhecolândia sub-region in South Pantanal, Central-West Brazil.
Memorias do Instituto Oswaldo Cruz    October 15, 2010   Volume 105, Issue 6 829-833 doi: 10.1590/s0074-02762010000600017
Pauvolid-Corrêa A, Tavares FN, Costa EV, Burlandy FM, Murta M, Pellegrin AO, Nogueira MF, Silva EE.As in humans, sub-clinical infection by arboviruses in domestic animals is common; however, its detection only occurs during epizootics and the silent circulation of some arboviruses may remain undetected. The objective of the present paper was to assess the current circulation of arboviruses in the Nhecolândia sub-region of South Pantanal, Brazil. Sera from a total of 135 horses, of which 75 were immunized with bivalent vaccine composed of inactive Eastern equine encephalitis virus (EEEV) and Western equine encephalitis virus(WEEV) and 60 were unvaccinated, were submitted to thorough viral i...
Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses.
Clinical and vaccine immunology : CVI    October 13, 2010   Volume 17, Issue 12 1896-1902 doi: 10.1128/CVI.00328-10
Ryan C, Giguère S.The objectives of this study were to compare relative vaccine-specific serum immunoglobulin concentrations, vaccine-specific lymphoproliferative responses, and cytokine profiles of proliferating lymphocytes between 3-day-old foals, 3-month-old foals, and adult horses after vaccination with a killed adjuvanted vaccine. Horses were vaccinated intramuscularly twice at 3-week intervals with a vaccine containing antigens from bovine viral respiratory pathogens to avoid interference from maternal antibody. Both groups of foals and adult horses responded to the vaccine with a significant increase in ...
Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection.
Veterinary immunology and immunopathology    October 7, 2010   Volume 139, Issue 2-4 128-140 doi: 10.1016/j.vetimm.2010.09.006
Adams AA, Sturgill TL, Breathnach CC, Chambers TM, Siger L, Minke JM, Horohov DW.Equine influenza virus is a leading cause of respiratory disease in the horse population; however, the susceptibility of old horses to EIV infection remains unknown. While advanced age in horses (>20 years) is associated with age-related changes in immune function, there are no specific recommendations regarding the vaccination of older horses even though a well-characterized effect of aging is a reduced antibody response to standard vaccination. Therefore, we evaluated the immunological and physiological response of aged horses to a live non-replicating canarypox-vectored EIV vaccine and s...
Needlestick and infection with horse vaccine.
BMJ case reports    August 26, 2010   Volume 2010 bcr1120092444 doi: 10.1136/bcr.11.2009.2444
Thompson RN, McNicholl BP.This report describes a case of accidental needlestick injury involving a live equine vaccination, Equilis StrepE. A vet presented herself to the Emergency Department having accidentally injected herself with an equine vaccination. Her left thumb (injury site) was inflamed and had lymphangitis progressing proximally along her left arm. Her inflammatory markers were not raised. The swelling, erythma and lymphangitis had improved markedly with intravenous antibiotics. She had no sequelae at follow-up. Equilis StrepE is a vaccine for submucosal administration containing a modified live avirulent ...
Low-dose DNA vaccination into the submandibular lymph nodes in ponies.
The Veterinary record    August 24, 2010   Volume 167, Issue 8 302-303 doi: 10.1136/vr.c3891
Landolt GA, Hussey SB, Kreutzer K, Quintana A, Lunn DP.No abstract available
Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
Vaccine    August 20, 2010   Volume 28, Issue 43 6989-6996 doi: 10.1016/j.vaccine.2010.08.043
Heldens JG, Pouwels HG, Derks CG, Van de Zande SM, Hoeijmakers MJ.Equine influenza is a contagious disease caused by equine influenza virus which belongs to the orthomyxovirus family. Outbreaks of equine influenza cause severe economic loses to the horse industry and consequently horses in competition are required to be regularly vaccinated against equine influenza. Unlike the existing inactivated vaccines, Equilis Prequenza Te is the only one able to induce protection against clinical disease and virus excretion after a primary vaccination course consisting of two vaccine applications 4-6 weeks apart until the recommended time of the third vaccination. In t...
Report of the Second Havemeyer EHV-1 Workshop, Steamboat Springs, Colorado, USA, September 2008.
Equine veterinary journal    August 19, 2010   Volume 42, Issue 6 572-575 doi: 10.1111/j.2042-3306.2010.00157.x
Kydd JH, Slater J, Osterrieder N, Antczak DF, Lunn DP.This report summarises the findings of the Second Havemeyer EHV-1 Workshop, which was held in Steamboat Springs, Colorado, USA in September 2008. A total of 38 delegates, consisting of veterinary clinicians and scientists from academia and industry participated in a series of sessions that focused on equine herpesvirus myeloencephalopathy (EHM). Each session consisted of a review, followed by short presentations on current research topics. The sessions included EHM epidemiology, in vivo and in vitro models for studying EHM, EHV-1 virulence determinants, real-time PCR diagnostics, antiviral med...
Equine influenza: a review of an unpredictable virus.
Veterinary journal (London, England : 1997)    August 3, 2010   Volume 189, Issue 1 7-14 doi: 10.1016/j.tvjl.2010.06.026
Daly JM, MacRae S, Newton JR, Wattrang E, Elton DM.This review discusses some of the challenges still faced in the control of equine influenza virus H3N8 infection. A widespread outbreak of equine influenza in the United Kingdom during 2003 in vaccinated Thoroughbred racehorses challenged the current dogma on vaccine strain selection. Furthermore, several new developments in the first decade of the 21st century, including transmission to and establishment in dogs, a presumed influenza-associated encephalopathy in horses and an outbreak of equine influenza in Australia, serve as a reminder of the unpredictable nature of influenza viruses. The a...
In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
Vaccine    July 16, 2010   Volume 28, Issue 39 6505-6517 doi: 10.1016/j.vaccine.2010.06.105
von Teichman BF, Dungu B, Smit TK.The polyvalent African horsesickness (AHS) attenuated live virus (AHS-ALV) vaccine produced at Onderstepoort Biological Products incorporates 7 of the 9 known serotypes circulating in southern Africa. Serological cross-reaction has been shown in vitro to Serotypes 5 and 9 by Serotypes 8 and 6 respectively, but the degree of in vivo cross-protection between these serotypes in vaccinated horses has not previously been reported. Due to the increasing incidence of AHS Serotypes 5 and 9 in the field, over the last 3-4 seasons of AHS in South Africa, and the absence of Serotypes 5 and 9 in the AHS-A...
Vaccine-associated fibrosarcoma.
Australian veterinary journal    June 10, 2010   Volume 88, Issue 5 159 doi: 10.1111/j.1751-0813.2010.00572.x
Homer DR.No abstract available
Control of EHV-1 viremia and nasal shedding by commercial vaccines.
Vaccine    June 9, 2010   Volume 28, Issue 32 5203-5211 doi: 10.1016/j.vaccine.2010.05.065
Goehring LS, Wagner B, Bigbie R, Hussey SB, Rao S, Morley PS, Lunn DP.Equine herpesvirus-1 is a cause of outbreaks of abortion and neurological disease. The pathogenesis of both these diseases depends on establishment of viremia. An experiment was performed to determine the protective efficacy of two commercially available vaccines used with an optimized 3-dose vaccination regime: a modified-live viral (MLV) and a high antigen load killed vaccine licensed for abortion control. The study design was a blinded, randomized challenge trial. Three groups of 8 yearling ponies received one of three treatments: MLV vaccine (Rhinomune, Boehringer Ingelheim Vetmedica, Inc....
1 12 13 14 15 16 29